DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vinorelbine (Vinorelbine) - Febrile Neutropenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Febrile Neutropenia (20)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vinorelbine where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vinorelbine side effects in 38 year old male

Reported by a consumer/non-health professional from Germany on 2012-08-09

Patient: 38 year old male

Reactions: Cellulitis, Febrile Neutropenia, Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: most recent infusion 18-nov-05 (2nd infusion).
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-10-20

Vinorelbine
    Dosage: most recent infusion 24-nov-05 (4th infusion).
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-10-20

Cetuximab
    Dosage: delayed on 30-nov-05. most recent infusion 24-nov-05 (6th infusion).
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-10-20



Possible Vinorelbine side effects in female

Reported by a physician from Chile on 2012-06-29

Patient: female, weighing 78.0 kg (171.6 pounds)

Reactions: Febrile Neutropenia

Drug(s) suspected as cause:
Vinorelbine
    Dosage: 20mgm2 cyclic
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-27

Lapatinib
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-27



Possible Vinorelbine side effects in 63 year old male

Reported by a consumer/non-health professional from Germany on 2012-06-28

Patient: 63 year old male

Reactions: Anaemia, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cetuximab
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-10-06

Cisplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-10-06

Vinorelbine
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-10-06



Possible Vinorelbine side effects in

Reported by a physician from United States on 2012-06-22

Patient:

Reactions: Thrombosis, Device Related Infection, Headache, Peripheral Sensory Neuropathy, Pericardial Effusion, Malaise, Dyspepsia, Granulocytopenia, Hypoxia, Pneumonitis, Blood Alkaline Phosphatase Increased, Hyperglycaemia, Anaemia, Hypotension, Dehydration, Neutropenia, Bone Pain, Pain, Hypokalaemia, Disease Progression, Death, Postoperative Wound Infection, Fatigue, Neutropenic Infection, Chest Pain, Depression, Lethargy, Vomiting, Dyspnoea, Alanine Aminotransferase Increased, Lymphopenia, Muscular Weakness, Febrile Neutropenia, Hypophosphataemia, Syncope, Diarrhoea, Arthralgia, Ejection Fraction Decreased, Hypermagnesaemia, Respiratory Tract Infection, Leukopenia, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Docetaxel
    Dosage: 60 mg/m2, unk
    Indication: Breast Cancer Metastatic

Vinorelbine
    Dosage: 27.5 mg/m2, per chemo regim
    Indication: Breast Cancer Metastatic

Filgrastim
    Dosage: 5 mug/kg, per chemo regim
    Indication: Breast Cancer Metastatic

Trastuzumab
    Dosage: 2 mg/kg, qwk

Trastuzumab
    Dosage: 4 mg/kg, one time dose
    Indication: Breast Cancer Metastatic



Possible Vinorelbine side effects in 14 year old female

Reported by a physician from United States on 2012-06-14

Patient: 14 year old female, weighing 55.0 kg (121.0 pounds)

Reactions: Atelectasis, Pneumonia, Hypotension, Febrile Neutropenia, Hypokalaemia, Pericardial Effusion, Hypoxia, Pleural Effusion, Pulmonary Oedema, Jugular Vein Thrombosis, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: day 1 over 30-60 minutes
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-14
    End date: 2012-02-14

Temsirolimus
    Dosage: days 1, 8 and 15 over 30-60 minutes
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-14
    End date: 2012-02-28

Vinorelbine
    Dosage: days 1 and 8, over 6-10 minutes
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-01
    End date: 2012-02-21



Possible Vinorelbine side effects in 14 year old female

Reported by a individual with unspecified qualification from United States on 2012-06-13

Patient: 14 year old female, weighing 55.0 kg (121.0 pounds)

Reactions: Atelectasis, Pneumonia, Hypotension, Tachycardia, Febrile Neutropenia, Pericardial Effusion, Hypokalaemia, Pulmonary Oedema, Pleural Effusion, Hypoxia, Jugular Vein Thrombosis, Pneumonitis, Oxygen Saturation Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vinorelbine
    Dosage: 25 mg/m2 iv
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-01
    End date: 2012-02-21

Cyclophosphamide
    Dosage: 1200 mg/m2 iv
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-14
    End date: 2012-02-14

Temsirolimus
    Dosage: 15 mg/m2 iv
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-14
    End date: 2012-02-28



Possible Vinorelbine side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-13

Patient: male

Reactions: Pneumonia, Interstitial Lung Disease, Hypotension, Chills, Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Mabthera
    Start date: 2010-05-07
    End date: 2010-11-10

Cytarabine
    Indication: Lymphoma
    Start date: 2010-09-03

Etoposide
    Indication: Lymphoma
    Start date: 2010-09-03
    End date: 2010-09-05

Carboplatin
    Indication: Lymphoma
    Start date: 2010-09-03
    End date: 2010-09-03

Gemcitabine Hydrochloride
    Indication: Lymphoma
    Start date: 2010-10-16
    End date: 2010-10-19

Ifosfamide
    Indication: Lymphoma
    Start date: 2010-10-16
    End date: 2010-10-19

Methylprednisolone
    Start date: 2010-11-11
    End date: 2010-11-14

Mabthera
    Dosage: vial 500 mg/50 ml
    Indication: Lymphoma
    Start date: 2010-05-07
    End date: 2010-10-05

Ifosfamide
    Start date: 2010-11-11
    End date: 2010-11-14

Vinorelbine
    Indication: Lymphoma
    Start date: 2010-10-19
    End date: 2010-10-20

Gemcitabine Hydrochloride
    Start date: 2010-11-11
    End date: 2010-11-14

Mabthera
    Dosage: vial 500 mg 50 ml
    End date: 2010-10-15

Vinorelbine
    Start date: 2010-11-11
    End date: 2010-11-14

Methylprednisolone
    Indication: Lymphoma
    Start date: 2010-10-16
    End date: 2010-10-19



Possible Vinorelbine side effects in 14 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-12

Patient: 14 year old female, weighing 55.0 kg (121.0 pounds)

Reactions: Atelectasis, Hypotension, Hypoxia, Pleural Effusion, Febrile Neutropenia, Pneumonitis, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Temsirolimus
    Dosage: 15 mg/m2, over 30-60 minutes on days 1, 8 and 15
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-14
    End date: 2012-02-28

Cyclophosphamide
    Dosage: 1200mg/m2, over 30-60 minutes on day 1
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-14
    End date: 2012-02-14

Vinorelbine
    Dosage: 25 mg/m2, over 6-10 minutes on days 1 and 8
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-01
    End date: 2012-02-21



Possible Vinorelbine side effects in male

Reported by a individual with unspecified qualification from United Kingdom on 2012-05-30

Patient: male, weighing 29.1 kg (64.0 pounds)

Reactions: Febrile Neutropenia, Herpes Zoster

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Sarcoma
    Start date: 2011-06-28

Vinorelbine
    Indication: Sarcoma
    Start date: 2012-04-20

Dactinomycin
    Indication: Sarcoma
    Start date: 2011-06-28

Cyclophosphamide
    Administration route: Oral
    Indication: Sarcoma
    Start date: 2012-04-20

Bevacizumab
    Indication: Sarcoma
    Start date: 2011-06-28
    End date: 2011-07-19

Ifosfamide
    Indication: Sarcoma
    Start date: 2011-06-28

Vincristine
    Indication: Sarcoma
    Start date: 2011-06-28

Bevacizumab
    Start date: 2012-04-20

Other drugs received by patient: Cotrim; Cotrim; Septra; Acetaminophen; Gabapentin



Possible Vinorelbine side effects in 65 year old male

Reported by a consumer/non-health professional from Ireland on 2012-05-23

Patient: 65 year old male

Reactions: Diarrhoea, Anaemia, Dehydration, Febrile Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-07-20

Vinorelbine
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-07-20

Cetuximab
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-07-20



Possible Vinorelbine side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-05-21

Patient: male

Reactions: Pneumonia, Interstitial Lung Disease, Hypotension, Chills, Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Indication: Lymphoma
    Start date: 2010-09-03

Methylprednisolone
    Start date: 2010-11-11
    End date: 2010-11-14

Carboplatin
    Indication: Lymphoma
    Start date: 2010-09-03
    End date: 2010-09-03

Ifosfamide
    Start date: 2010-11-11
    End date: 2010-11-14

Mabthera
    Indication: Lymphoma
    Start date: 2010-05-07
    End date: 2010-10-05

Etoposide
    Indication: Lymphoma
    Start date: 2010-09-03
    End date: 2010-09-05

Vinorelbine
    Start date: 2010-11-11
    End date: 2010-11-14

Gemcitabine Hydrochloride
    Indication: Lymphoma
    Start date: 2010-10-16
    End date: 2010-10-19

Gemcitabine Hydrochloride
    Start date: 2010-11-11
    End date: 2010-11-14

Methylprednisolone
    Indication: Lymphoma
    Start date: 2010-10-16
    End date: 2010-10-19

Mabthera
    End date: 2010-11-10

Ifosfamide
    Indication: Lymphoma
    Start date: 2010-10-16
    End date: 2010-10-19

Vinorelbine
    Indication: Lymphoma
    Start date: 2010-10-19
    End date: 2010-10-20

Mabthera
    End date: 2010-10-15



Possible Vinorelbine side effects in 14 year old female

Reported by a physician from United States on 2012-05-16

Patient: 14 year old female, weighing 55.0 kg (121.0 pounds)

Reactions: Atelectasis, Hypotension, Hypoxia, Pleural Effusion, Febrile Neutropenia, Hypokalaemia, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1200mg/m2, over 30-60 minutes on day 1
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-14
    End date: 2012-02-14

Vinorelbine
    Dosage: 25 mg/m2, over 6-10 minutes on days 1 and 8
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-01
    End date: 2012-02-21

Temsirolimus
    Dosage: 15 mg/m2, over 30-60 minutes on days 1, 8 and 15
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-14
    End date: 2012-02-28



Possible Vinorelbine side effects in female

Reported by a physician from Peru on 2012-05-09

Patient: female, weighing 69.5 kg (152.9 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lapatinib
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer

Vinorelbine
    Dosage: 44mg cyclic
    Indication: Breast Cancer



Possible Vinorelbine side effects in female

Reported by a physician from Chile on 2012-05-07

Patient: female, weighing 78.0 kg (171.6 pounds)

Reactions: Febrile Neutropenia

Drug(s) suspected as cause:
Lapatinib
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-27

Vinorelbine
    Dosage: 20mgm2 cyclic
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-27



Possible Vinorelbine side effects in female

Reported by a physician from Peru on 2012-04-23

Patient: female, weighing 69.5 kg (152.9 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vinorelbine
    Dosage: 44mg cyclic
    Indication: Breast Cancer

Lapatinib
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer



Possible Vinorelbine side effects in 14 year old female

Reported by a physician from United States on 2012-04-11

Patient: 14 year old female, weighing 55.0 kg (121.0 pounds)

Reactions: Atelectasis, Hypotension, Pleural Effusion, Febrile Neutropenia, Hypoxia, Pneumonitis, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vinorelbine
    Dosage: 25 mg/m2 iv over 6-10 minutes on days 1 and 8
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-01
    End date: 2012-02-21

Temsirolimus
    Dosage: 15 mg/m2 iv over 30-60 minutes on days 1, 8 and 15
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-14
    End date: 2012-02-28

Cyclophosphamide
    Dosage: 1200mg/m2/dose iv over 30-60 minutes on day 1
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-14
    End date: 2012-02-14



Possible Vinorelbine side effects in 63 year old male

Reported by a pharmacist from United States on 2012-04-02

Patient: 63 year old male, weighing 69.5 kg (152.9 pounds)

Reactions: Wheezing, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 660 mg once iv
    Indication: non-Small Cell Lung Cancer Stage IV
    Start date: 2011-12-08
    End date: 2012-01-05

Vinorelbine
    Dosage: 35 mg qweek iv
    Indication: non-Small Cell Lung Cancer Stage IV
    Start date: 2011-12-29
    End date: 2012-01-05



Possible Vinorelbine side effects in female

Reported by a physician from Italy on 2012-02-22

Patient: female, weighing 45.0 kg (99.0 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Placebo
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-01
    End date: 2012-01-22

Vinorelbine
    Dosage: 25 mg/kg, unk
    Indication: Breast Cancer Metastatic
    Start date: 2011-11-30
    End date: 2012-01-17

Blinded NO Treatment Received
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-01
    End date: 2012-01-22

Comparator Trastuzumab
    Dosage: 6 mg/kg, unk
    Indication: Breast Cancer Metastatic
    Start date: 2011-11-30
    End date: 2012-01-17

Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-01
    End date: 2012-01-22



Possible Vinorelbine side effects in female

Reported by a physician from Poland on 2011-12-09

Patient: female, weighing 50.7 kg (111.5 pounds)

Reactions: Diarrhoea, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vinorelbine
    Dosage: 20mgm2 cyclic
    Indication: Breast Cancer Metastatic
    Start date: 2011-11-21

Lapatinib
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-07-04

Capecitabine
    Dosage: 2000mgm2 cyclic
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-07-04
    End date: 2011-11-14

Other drugs received by patient: Omeprazole



Possible Vinorelbine side effects in female

Reported by a physician from Poland on 2011-11-30

Patient: female, weighing 50.7 kg (111.5 pounds)

Reactions: Diarrhoea, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lapatinib
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-07-04

Capecitabine
    Dosage: 2000mgm2 cyclic
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-07-04
    End date: 2011-11-14

Vinorelbine
    Dosage: 20mgm2 cyclic
    Indication: Breast Cancer Metastatic
    Start date: 2011-11-21

Other drugs received by patient: Omeprazole

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017